Crosstalk in glomerular injury and repair

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 3, 2015, Pages 231-238

  Dimke, Henrik ^a   Maezawa, Yoshiro ^b,c   Quaggin, Susan E ^d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

activated protein C; angiopoietin; C X C chemokine ligand 12; endothelin 1; vascular endothelial growth factor

Indexed keywords

ACTIVATED PROTEIN C; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CXCL2 CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INTERLEUKIN 6; PLASMA PROTEIN; PROTEINASE ACTIVATED RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; VASCULOTROPIN A;

BLOOD FILTRATION; CELL COMMUNICATION; CELL JUNCTION; ENDOTHELIUM CELL; GLOMERULAR FILTRATION BARRIER; GLOMERULAR INJURY; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HUMAN; INTRAGLOMERULAR ENDOTHELIAL CELL; MESANGIUM CELL; MOLECULAR INTERACTION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; REVIEW; ANIMAL; CAPILLARY; CHEMISTRY; INJURIES; KIDNEY DISEASES; METABOLISM;

ANIMALS; CAPILLARIES; ENDOTHELIAL CELLS; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MESANGIAL CELLS; PODOCYTES;

EID: 84928468793     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000117     Document Type: Review

References (40)

1. Vaughan MR, Quaggin SE. How do mesangial and endothelial cells form the glomerular tuft? J Am Soc Nephrol 2008; 19:24-33.
2. Maezawa Y, Cina D, Quaggin SE. Glomerular cell biology. In: Alpern R, Caplan M, Moe O, editors. Seldin and Giebisch's the kidney: physiology and pathophysiology. San Diego: Elsevier; 2012; vol 1. pp. 721-756.
3. Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111:707-716.
4. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-439.
5. Dimke H, Sparks MA, Thomson BR, et al. Tubulovascular cross-talk by vascular endothelial growth factor A maintains peritubular microvasculature in kidney. J Am Soc Nephrol 2014; doi: 10.1681/ASN.2014010060. [Epub ahead of print]
6. Veron D, Villegas G, Aggarwal PK, et al. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. PLoS One 2012; 7:e40589.
7. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358:1129-1136.
8. Sivaskandarajah GA, Jeansson M, Maezawa Y, et al. Vegfa protects the glomerular microvasculature in diabetes. Diabetes 2012; 61:2958-2966.
9. Veron D, Bertuccio CA, Marlier A, et al. Podocyte vascular endothelial growth factor (Vegf(1)(6)(4)) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 2011; 54:1227-1241.
10. Kim SI, Lee SY, Wang Z, et al. TGF-beta-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation. J Am Soc Nephrol 2014; 25:1966-1978.
11. Maezawa Y, Onay T, Scott RP, et al. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS. J Am Soc Nephrol 2014; 25:2459-2470.
12. Sison K, Eremina V, Baelde H, et al. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 2010; 21:1691-1701.
13. Jin J, Sison K, Li C, et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 2012; 151:384-399.
14. Ku CH, White KE, Dei Cas A, et al. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 2008; 57:2824-2833.
15. Hinamoto N, Maeshima Y, Yamasaki H, et al. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1. PLoS One 2014; 9:e107934.
16. Thomson BR, Heinen S, Jeansson M, et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J Clin Invest 2014; 124: 4320-4324.
17. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180.
18. Jeansson M,Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121:2278-2289.
19. Dessapt-Baradez C, Woolf AS, White KE, et al. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol 2014; 25:33-42.
20. Davis B, Dei Cas A, Long DA, et al. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007; 18:2320-2329.
21. Clement LC, Avila-Casado C, Mace C, et al. Podocyte-secreted angiopoietinlike-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011; 17:117-122.
22. Clement LC, Mace C, Avila-Casado C, et al. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 2014; 20:37-46.
23. Takabatake Y, Sugiyama T, Kohara H, et al. The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009; 20:1714-1723.
24. Sayyed SG, Hagele H, Kulkarni OP, et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009; 52:2445-2454.
25. Haege S, Einer C, Thiele S, et al. CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney. PLoS One 2012; 7:e42814.
26. Petruzziello-Pellegrini TN, Yuen DA, Page AV, et al. The CXCR4/CXCR7/ SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012; 122: 759-776.
27. Kuravi SJ, McGettrick HM, Satchell SC, et al. Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk. J Immunol 2014; 193:234-243.
28. Isermann B, Vinnikov IA, Madhusudhan T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007; 13:1349-1358.
29. Madhusudhan T, Wang H, Straub BK, et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood 2012; 119:874-883.
30. Bock F, Shahzad K, Wang H, et al. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci USA 2013; 110:648-653.
31. Daehn I, Casalena G, Zhang T, et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 2014; 124:1608-1621.
32. Lenoir O, Milon M, Virsolvy A, et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J Am Soc Nephrol 2014; 25:1050-1062.
33. Yuen DA, Stead BE, Zhang Y, et al. eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol 2012; 23:1810-1823.
34. Veron D, Aggarwal PK, Velazquez H, et al. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice. J Am Soc Nephrol 2014; 25:1814-1824.
35. Lindahl P, Hellstrom M, Kalen M, et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998; 125:3313-3322.
36. Lindahl P, Johansson BR, Leveen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242-245.
37. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994; 8: 1888-1896.
38. Bjarnegard M, EngeM, Norlin J, et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004; 131:1847-1857.
39. Khan S, Lakhe-Reddy S, McCarty JH, et al. Mesangial cell integrin alphavbeta8 provides glomerular endothelial cell cytoprotection by sequestering TGF-beta and regulating PECAM-1. Am J Pathol 2011; 178: 609-620.
40. Schlondorff D, Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 2009; 20:1179-1187.